Vectans Pharma
Records under this name other than patents Vectans Pharma holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to Vectans Pharma
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,791,127 | Mucosal Bioadhesive Slow Release Carrier for Delivering Active Principles Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,747,896 | Mucosal Bioadhesive Slow Release Carrier for Delivering Active Principles Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,211,466 | Mucosal Bioadhesive Slow Release Carrier for Delivering Active Principles Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,592,434 | Mucoadhesive Buccal Tablets for the Treatment of Orofacial Herpes Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 7,651,698 | Prolonged release bioadhesive therapeutic systems Term ended Term ended Aug 15, 2024 · From the USPTO record | Term ended | Term ended Aug 15, 2024 | From the USPTO record |
| US 8,518,442 | Prolonged release bioadhesive therapeutic systems Term ended Term ended Nov 21, 2022 · From the USPTO record | Term ended | Term ended Nov 21, 2022 | From the USPTO record |
| US 6,916,485 | Prolonged Release Bioadhesive Therapeutic Systems Term ended Term ended Sep 11, 2022 · High confidence | Term ended | Term ended Sep 11, 2022 | High confidence |